Organization · Venture Capital
Vie Ventures
Vie Ventures is a life sciences venture capital firm based in Cambridge, Massachusetts, focused on developing innovative therapeutics for autoimmune diseases. It uniquely integrates venture capital with disease-focused philanthropy to enhance patient outcomes while generating financial returns.
Overview
What Vie Ventures does
What Vie Ventures is
Vie Ventures is a life sciences venture capital firm based in Cambridge, Massachusetts, focused on developing innovative therapeutics for autoimmune diseases. It uniquely integrates venture capital with disease-focused philanthropy to enhance patient outcomes while generating financial returns.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2025
- Approximate age
- About 1 year
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Vie Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Vie Ventures as a funder
Investment thesis
Vie Ventures focuses on the intersection of life sciences venture capital and disease philanthropy, aiming to develop innovative therapeutics for autoimmune diseases and disorders of the immune system. The firm believes that the autoimmune disease space represents a significant area of unmet medical need and a productive period for biotechnology innovation.
Focus narrative
Vie Ventures invests in therapeutic companies that are pioneering next-generation therapies specifically targeting autoimmune diseases. The firm aims to generate financial returns while making a mission-driven impact, utilizing its strategic partnerships within the biotech ecosystem to support portfolio companies.
Value beyond capital
Vie Ventures provides its portfolio companies with access to a network of disease-focused philanthropic organizations, patient communities, and regulatory expertise, which can significantly enhance their development processes and market positioning. This collaborative model aims to unlock unique insights and support that traditional biotech VCs may not offer.
Focus and fit
- Stages
- Series B · Series C
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
As of May 2026, Vie Ventures has not publicly disclosed specific portfolio companies, as the firm launched in July 2025 and is still in the process of announcing individual investments.
Common questions
What to know about Vie Ventures
Upseed classifies Vie Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.